We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
+8.89%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$478M
AUM Growth
+$7.73M
Cap. Flow
-$9.25M
Cap. Flow %
-1.94%
Top 10 Hldgs %
18.63%
Holding
191
New
31
Increased
71
Reduced
35
Closed
38

Sector Composition

Rank Sector Weight
1 Financials 18.39%
2 Technology 17.19%
3 Industrials 14.57%
4 Consumer Discretionary 13.35%
5 Healthcare 12.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VC icon
76
Visteon
VC
$2.78B
$2.84M 0.59%
41,025
+992
+2% +$73.3K
AIN icon
77
Albany International
AIN
$1.78B
$2.81M 0.59%
56,773
+1,351
+2% +$70K
QTRX icon
78
Quanterix
QTRX
$190M
$2.81M 0.59%
83,197
+1,495
+2% +$48.1K
IGMS
79
DELISTED
IGM Biosciences
IGMS
$2.79M 0.58%
37,737
+18,864
+100% +$1.12M
FIX icon
80
Comfort Systems
FIX
$59.6B
$2.78M 0.58%
54,003
+1,312
+2% +$63.7K
KMT icon
81
Kennametal
KMT
$2.52B
$2.56M 0.54%
88,591
-82,977
-48% -$2.41M
EBS icon
82
Emergent Biosolutions
EBS
$248M
$2.45M 0.51%
23,696
+12,094
+104% +$1.3M
KRTX
83
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$2.4M 0.5%
30,970
+672
+2% +$57.3K
NVAX icon
84
Novavax
NVAX
$1.31B
$2.39M 0.5%
22,061
-2,596
-11% -$316K
VIVO
85
DELISTED
Meridian Bioscience Inc
VIVO
$2.32M 0.49%
136,650
+81,440
+148% +$1.58M
KYNB
86
Kyntra Bio
KYNB
$29.4M
$2.28M 0.48%
2,221
+61
+3% +$65.6K
IOVA icon
87
Iovance Biotherapeutics
IOVA
$2.87B
$2.16M 0.45%
65,707
+952
+1% +$29.2K
RARE icon
88
Ultragenyx Pharmaceutical
RARE
$2.55B
$2.11M 0.44%
+25,672
New +$2.13M
SYNA icon
89
Synaptics
SYNA
$4.15B
$2.11M 0.44%
+26,228
New +$2.07M
DRNA
90
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.73M 0.36%
95,971
+2,303
+2% +$47.7K
ZYME icon
91
Zymeworks
ZYME
$1.67B
$1.53M 0.32%
32,824
+787
+2% +$27K
AB icon
92
AllianceBernstein
AB
$3.47B
$1.52M 0.32%
56,217
+12,890
+30% +$361K
EHTH icon
93
eHealth
EHTH
$43.9M
$1.34M 0.28%
17,014
+428
+3% +$34.7K
SYF icon
94
Synchrony
SYF
$25.6B
$1.32M 0.28%
50,551
+12,558
+33% +$305K
RS icon
95
Reliance Steel & Aluminium
RS
$21.6B
$1.3M 0.27%
12,709
RHI icon
96
Robert Half
RHI
$4.37B
$1.25M 0.26%
23,549
LAZ icon
97
Lazard
LAZ
$4.31B
$1.23M 0.26%
37,063
+11,898
+47% +$367K
THG icon
98
Hanover Insurance
THG
$7.98B
$1.15M 0.24%
12,351
CCXI
99
DELISTED
ChemoCentryx, Inc.
CCXI
$1.12M 0.23%
+20,499
New +$1.1M
DFS
100
DELISTED
Discover Financial Services
DFS
$1.11M 0.23%
19,298

Similar funds

Moody Aldrich Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Moody Aldrich Partners held 191 positions worth $478M, up 1.6% from $470M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Moody Aldrich Partners's Q3 2020 filing shows 31 new, 71 increased, 35 reduced and 38 closed positions. Its largest new stake was Focus Financial Partners Inc. Class A: 265,156 shares worth $8.69M. The largest sale was CMC Materials, Inc. Common Stock, an estimated $7.95M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.

  • Moody Aldrich Partners's largest Q3 2020 buy was Focus Financial Partners Inc. Class A: 265,156 shares worth $8.69M.
  • Moody Aldrich Partners added most to SiteOne Landscape Supply in Q3 2020, an estimated $3.28M increase.
  • Moody Aldrich Partners's biggest Q3 2020 reduction was IAA, Inc. Common Stock, cutting an estimated $3.88M.
  • Moody Aldrich Partners fully exited CMC Materials, Inc. Common Stock in Q3 2020, selling an estimated $7.95M.
  • Moody Aldrich Partners's ten largest holdings make up 19% of its $478M portfolio in Q3 2020.
  • Moody Aldrich Partners opened 31 new positions and closed 38 in Q3 2020.
  • Moody Aldrich Partners's portfolio value rose 1.6% quarter-over-quarter to $478M.

Based on Moody Aldrich Partners's 13F filing for Q3 2020, filed 12 Nov 2020.